Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy.
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy.
复制标题
DOI：
10.1038/s41598-018-26509-y
复制
发表时间：
2018-05-29
影响因子：
4.6
通讯作者：
Merli M
中科院分区：
文献类型：
--
作者：
Iebba V;Guerrieri F;Di Gregorio V;Levrero M;Gagliardi A;Santangelo F;Sobolev AP;Circi S;Giannelli V;Mannina L;Schippa S;Merli M
In liver cirrhosis (LC), impaired intestinal functions lead to dysbiosis and possible bacterial translocation (BT). Bacteria or their byproducts within the bloodstream can thus play a role in systemic inflammation and hepatic encephalopathy (HE). We combined 16S sequencing, NMR metabolomics and network analysis to describe the interrelationships of members of the microbiota in LC biopsies, faeces, peripheral/portal blood and faecal metabolites with clinical parameters. LC faeces and biopsies showed marked dysbiosis with a heightened proportion of Enterobacteriaceae. Our approach showed impaired faecal bacterial metabolism of short-chain fatty acids (SCFAs) and carbon/methane sources in LC, along with an enhanced stress-related response. Sixteen species, mainly belonging to the Proteobacteria phylum, were shared between LC peripheral and portal blood and were functionally linked to iron metabolism. Faecal Enterobacteriaceae and trimethylamine were positively correlated with blood proinflammatory cytokines, while Ruminococcaceae and SCFAs played a protective role. Within the peripheral blood and faeces, certain species (Stenotrophomonas pavanii, Methylobacterium extorquens) and metabolites (methanol, threonine) were positively related to HE. Cirrhotic patients thus harbour a ‘functional dysbiosis’ in the faeces and peripheral/portal blood, with specific keystone species and metabolites related to clinical markers of systemic inflammation and HE.
登录
查看更多内容
影响因子：
4.3
作者：
Faust K;Sathirapongsasuti JF;Izard J;Segata N;Gevers D;Raes J;Huttenhower C
通讯作者：
Huttenhower C
影响因子：
2.2
作者：
Cadenas, Maria B.;Maggi, Ricardo G.;Breithschwerdt, Edward B.
通讯作者：
Breithschwerdt, Edward B.
影响因子：
4.2
作者：
Aly, AbdelRahman Mahmoud;Adel, AbdelReheem;Aziz, Ramy K.
通讯作者：
Aziz, Ramy K.
影响因子：
6.8
作者：
Allen AP;Hutch W;Borre YE;Kennedy PJ;Temko A;Boylan G;Murphy E;Cryan JF;Dinan TG;Clarke G
通讯作者：
Clarke G
影响因子：
64.5
作者：
Goodrich JK;Di Rienzi SC;Poole AC;Koren O;Walters WA;Caporaso JG;Knight R;Ley RE
通讯作者：
Ley RE